Jan 12, 2021 / 01:20PM GMT
Cory William Kasimov - JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst
All right. Good morning from the virtual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap Biotech Analyst, and it's my pleasure to introduce our next company, NovoCure, and Executive Chairman, Bill Doyle.
Please note that following this presentation, we will have a Q&A session where you have the ability to submit questions via the little blue, ask-a-question button in your conference portal. So with that, Bill, thanks for being here today, and let me turn things over to you.
William F. Doyle - NovoCure Limited - Executive Chairman
Hello, Cory. Good morning. I'm joining you from NovoCure's operations center in Portsmouth, New Hampshire. And I want to say hello to everybody. Good morning to everyone in the U.S., and hello to everyone in the rest of the world.
I'm going to call out the numbers of the slides that I'm going to be presenting this morning, so that everyone can follow along. I'll start with Slide 2. I
Novocure Ltd at JPMorgan Healthcare Conference (Virtual) Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers